SIRANUSH KHALADZHYAN: Open Payments
NPI 1427780030 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,551 in 76 payments from 17 companies in 2025. Trend: 2023 $1,316 · 2024 $2,903 · 2025 $1,551
Food & beverage: $1,551
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $247 |
| Novartis Pharmaceuticals Corporation | 11 | $214 |
| Eisai Inc. | 12 | $153 |
| UCB, Inc. | 5 | $120 |
| ARGENX US, INC. | 5 | $113 |
| PFIZER INC. | 5 | $109 |
| E.R. Squibb & Sons, L.L.C. | 1 | $104 |
| EMD Serono, Inc. | 3 | $86 |
| Biogen, Inc. | 4 | $82 |
| Lundbeck LLC | 2 | $64 |
Products named: KESIMPTA, Leqembi, ZEPOSIA, QULIPTA, VYVGART HYTRULO, NURTEC ODT, UBRELVY, TYSABRI.
Industry payments across NV — which companies pay providers there.
